TY - JOUR
T1 - A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy
T2 - The NeuroCOVID-19 Task Force of the European Academy of Neurology
AU - Sellner, Johann
AU - Jenkins, Thomas M
AU - von Oertzen, Tim J
AU - Bassetti, Claudio L
AU - Beghi, Ettore
AU - Bereczki, Daniel
AU - Bodini, Benedetta
AU - Cavallieri, Francesco
AU - Di Liberto, Giovanni
AU - Helbok, Raimund
AU - Macerollo, Antonella
AU - Maia, Luis F
AU - Oreja-Guevara, Celia
AU - Özturk, Serefnur
AU - Rakusa, Martin
AU - Pisani, Antonio
AU - Priori, Alberto
AU - Sauerbier, Anna
AU - Soffietti, Riccardo
AU - Taba, Pille
AU - Zedde, Marialuisa
AU - Crean, Michael
AU - Burlica, Anja
AU - Twardzik, Alex
AU - Moro, Elena
N1 - © 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
PY - 2021/1/18
Y1 - 2021/1/18
N2 - Coronavirus disease 2019 (COVID-19), a multi-organ disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurological disease. COVID-19 appears to have exposed inequalities of societies and healthcare systems and had a disproportionate impact on already vulnerable communities. The next challenge will be to set up initiatives to stop disparities in all aspects related to COVID-19. From the medical perspective, there is a need to consider inequalities in prevention, treatment and long-term consequences. Some of the issues of direct relevance to neurologists are summarised. With this appraisal, the European Academy of Neurology NeuroCOVID-19 Task Force intends to raise awareness of the potential impact of COVID-19 on inequalities in healthcare and calls for action to prevent disparity at individual, national and supranational levels.
AB - Coronavirus disease 2019 (COVID-19), a multi-organ disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurological disease. COVID-19 appears to have exposed inequalities of societies and healthcare systems and had a disproportionate impact on already vulnerable communities. The next challenge will be to set up initiatives to stop disparities in all aspects related to COVID-19. From the medical perspective, there is a need to consider inequalities in prevention, treatment and long-term consequences. Some of the issues of direct relevance to neurologists are summarised. With this appraisal, the European Academy of Neurology NeuroCOVID-19 Task Force intends to raise awareness of the potential impact of COVID-19 on inequalities in healthcare and calls for action to prevent disparity at individual, national and supranational levels.
U2 - 10.1111/ene.14741
DO - 10.1111/ene.14741
M3 - Article
C2 - 33460486
JO - European Journal of Neurology
JF - European Journal of Neurology
SN - 1351-5101
ER -